Post

The Wall Street Journal
@wsj.com

The little-discussed potential risk of popular diabetes and weight-loss drugs is on warning labels outside of the U.S. on.wsj.com/4j6drh2

on.wsj.comPatients are suing GLP-1 drugmakers over the risk of sudden vision loss. The little-discussed potential risk of popular diabetes and weight-loss drugs is on warning labels outside of the U.S.The little-discussed potential risk of popular diabetes and weight-loss drugs is on warning labels outside of the U.S.

9 reposts20 likes

No replies yet.